Combination antiarrhythmic therapy for management of malignant ventricular arrhythmia
- 3 November 1988
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 62 (14) , I18-I21
- https://doi.org/10.1016/0002-9149(88)91343-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Long-term efficacy of mexiletine alone and in combination with class la antiarrhythmic drugs for refractory ventricular arrhythmiasAmerican Heart Journal, 1988
- Combination Antiarrhythmic Drug Therapy For Ventricular TachyarrhythmiasPacing and Clinical Electrophysiology, 1986
- Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery diseaseThe American Journal of Cardiology, 1985
- Safety of maximal exercise testing in patients at high risk for ventricular arrhythmia.Circulation, 1984
- Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.Circulation, 1983
- Mexiletine for control of drug-resistant ventricular tachycardia: Clinical and electrophysiologic results in 44 patientsThe American Journal of Cardiology, 1983
- Quinidine for ventricular arrhythmias: Value of electrophysiologic testingThe American Journal of Cardiology, 1983
- Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugsThe American Journal of Cardiology, 1982
- Comparison of the Antiarrhythmic Efficacy of Disopyramide and Mexiletine Against Stimulus-Induced Ventricular TachycardiaJournal of Cardiovascular Pharmacology, 1981
- Approaches to Sudden Death from Coronary Heart DiseaseCirculation, 1971